These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29450658)

  • 1. Modified Allergens for Immunotherapy.
    Satitsuksanoa P; Głobińska A; Jansen K; van de Veen W; Akdis M
    Curr Allergy Asthma Rep; 2018 Feb; 18(2):9. PubMed ID: 29450658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
    Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
    Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).
    Klimek L; Pfaar O; Worm M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1123-35. PubMed ID: 27191353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to immunotherapy in house dust mite allergy.
    Kim IS
    Clin Exp Pediatr; 2023 Apr; 66(4):161-168. PubMed ID: 36397261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on immunotherapy in airway allergen sensitised patients.
    van der Valk JP; de Jong NW; Gerth van Wijk R
    Neth J Med; 2015 Jul; 73(6):263-9. PubMed ID: 26228190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal challenges in allergen immunotherapy trials.
    Tenn MW; Rawls M; Ellis AK
    Curr Opin Allergy Clin Immunol; 2018 Dec; 18(6):489-494. PubMed ID: 30199379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of allergies: current status].
    Mahler V; Kleine-Tebbe J; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant allergens, peptides, and virus-like particles for allergy immunotherapy].
    Holzhauser T; Schuler F; Dudek S; Kaul S; Vieths S; Mahler V
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1412-1423. PubMed ID: 33095280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of house dust mite allergy.
    Yang L; Zhu R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of Novel Vaccination Strategies in Allergen Immunotherapy.
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):15-24. PubMed ID: 31761116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass pollen immunotherapy: where are we now.
    Würtzen PA; Gupta S; Brand S; Andersen PS
    Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
    Asero R; Mistrello G; Amato S
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens.
    Gafvelin G; Parmley S; Neimert-Andersson T; Blank U; Eriksson TL; van Hage M; Punnonen J
    J Biol Chem; 2007 Feb; 282(6):3778-87. PubMed ID: 17170112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.
    Mueller RS; Jensen-Jarolim E; Roth-Walter F; Marti E; Janda J; Seida AA; DeBoer D
    Allergy; 2018 Oct; 73(10):1989-1999. PubMed ID: 29675865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
    Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
    J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.